News Sentiment

SEPN sentiment intelligence

Septerna, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 35.93 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+5.7% over one week, -0.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Septerna president & COO Elizabeth Bhatt sells $135,974 in stock

Market Reaction

Price moving ahead of tone

65/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 5.7% Price confirming higher
Trend fit Trend active -0.1% over four weeks
Fair value 82.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 29
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 11
Investing.com 4
Quiver Quantitative 2
www.marketscreener.com 2
TradingView 2
simplywall.st 2
TIKR.com 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 18
Analyst action 5
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 52
Investing.com Nigeria Direct company coverage

Form 4 Septerna Inc For: 17 July By Investing.com

This article from Investing.com announces the filing of Form 4 for Septerna Inc. on July 17. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders whenever they buy or sell shares of their company's stock. The article i

Tone
Positive 60/100
Event
Market update
Published
17 Jul 2026 23:11
Source
Investing.com Nigeria
Stock Titan Direct company coverage

[144] Septerna, Inc. SEC Filing

This article reports on a Form 144 SEC filing by Septerna, Inc. (SEPN) on July 15, 2026. The filing indicates a proposed sale of 4000 shares of common stock with an aggregate market value of $138,160.00, acquired through the exercise of stock options. The neutrality of the filing

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 20:46
Source
Stock Titan
Sahm Direct company coverage

Septerna (SEPN) Is Up 7.1% After Broad Russell Growth Index Additions Has The Bull Case Changed?

Septerna (SEPN) experienced a 7.1% stock increase following its inclusion in several Russell growth and small-cap indices in June 2026. While this broad index inclusion boosts visibility and eligibility for index-tracking funds, it doesn't fundamentally alter the immediate invest

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 16:09
Source
Sahm
Investing.com Direct company coverage

Septerna Inc stock hits all-time high at 38.01 USD

Septerna Inc (SEPN) stock has reached an all-time high of $38.01, marking a significant milestone for the biotech firm with a market capitalization of $1.71 billion. The company has seen a 224.66% increase in its stock price over the past year, reflecting strong investor confiden

Tone
Positive 72/100
Event
Market update
Published
10 Jul 2026 09:10
Source
Investing.com
Investing.com India Direct company coverage

Septerna Inc stock hits all-time high at 38.01 USD By Investing.com

Septerna Inc's stock has reached an all-time high of $38.01, bringing its market capitalization to $1.71 billion. The company has seen a 224.66% increase in its stock price over the past year, reflecting strong investor confidence and strategic advancements. Analysts have varied

Tone
Positive 81/100
Event
Market update
Published
09 Jul 2026 21:09
Source
Investing.com India
Stock Titan Direct company coverage

If You Invested $1,000 in Septerna, Inc. (SEPN)

This article analyzes the hypothetical return on a $1,000 investment in Septerna, Inc. (SEPN), a clinical-stage biotechnology company specializing in GPCR-targeted therapies. An investment made one year ago would have yielded a 213.4% return, turning $1,000 into $3,134. The compa

Tone
Positive 72/100
Event
Market update
Published
04 Jul 2026 07:11
Source
Stock Titan
Stock Titan Direct company coverage

Septerna (SEPN) SVP Long exercises options and sells 3,333 shares in Rule 10b5-1 trades

Daniel D. Long, Senior Vice President of Drug Discovery at Septerna, Inc. (SEPN), exercised stock options to acquire 3,333 shares at $2.76 each and simultaneously sold these 3,333 shares in open-market transactions on July 1, 2026. The sales were conducted under a pre-arranged Ru

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 22:39
Source
Stock Titan
The Globe and Mail Direct company coverage

Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Strategy (MSTR)

Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Septerna, Inc. (SEPN) with a $45.00 price target, reflecting a current consensus Strong Buy with a 38.9% upside. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating on Strategy (MSTR) with a $130.00 price ta

Tone
Positive 76/100
Event
Analyst action
Published
02 Jul 2026 11:14
Source
The Globe and Mail
www.marketscreener.com Direct company coverage

Truist Securities Adjusts Septerna Price Target to $43 From $35, Maintains Buy Rating

Truist Securities has increased its price target for Septerna, Inc. (NasdaqGM:SEPN) to $43 from $35, while reiterating a "Buy" rating on the stock. This adjustment reflects an updated positive outlook from the firm regarding the biotechnology company. Septerna is a clinical-stage

Tone
Positive 70/100
Event
Analyst action
Published
01 Jul 2026 12:42
Source
www.marketscreener.com
Simply Wall Street Direct company coverage

Septerna (SEPN) Is Down 7.1% After Broad Russell Index Additions Has The Bull Case Changed?

Septerna, Inc. (NasdaqGM: SEPN) was recently added to several Russell growth and small-cap indexes in late June 2026, which could increase its visibility among institutional investors. Despite a recent 7-day share price decline, this index inclusion primarily impacts trading liqu

Tone
Negative 39/100
Event
Market update
Published
01 Jul 2026 12:42
Source
Simply Wall Street
Investing.com Canada Direct company coverage

Septerna stock maintained at Buy by H.C. Wainwright after rival setback

H.C. Wainwright has reiterated a Buy rating and a $40 price target for Septerna Inc (NASDAQ:SEPN) despite a competitor's negative Phase 2b data in chronic spontaneous urticaria. The firm maintains that Septerna's drug SEP-631, which targets the same condition, still has potential

Tone
Positive 72/100
Event
Analyst action
Published
01 Jul 2026 11:42
Source
Investing.com Canada
Investing.com Direct company coverage

Guggenheim cuts Septerna stock price target to $45 on CSU study risk

Guggenheim lowered its price target for Septerna Inc. (NASDAQ:SEPN) to $45 from $52, while maintaining a Buy rating. This adjustment follows a competitor's failed Phase 2b study for chronic spontaneous urticaria (CSU), increasing the perceived risk for Septerna's similar drug can

Tone
Negative 38/100
Event
Analyst action
Published
01 Jul 2026 07:26
Source
Investing.com
Stock Titan Direct company coverage

Septerna (SEPN) director Abraham Bassan receives grant of 15,000 stock options

Septerna, Inc. director Abraham Bassan was granted 15,000 stock options with an exercise price of $37.34 per share, expiring on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the date of Septerna's next annual meeting of stockholders, provided

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 06:09
Source
Stock Titan
Investing.com Direct company coverage

Septerna chief people officer Samira Shaikhly sells $76,622 in stock

Samira Shaikhly, Septerna's Chief People Officer, sold 2,178 shares of the company's common stock for $76,622 after exercising stock options. The sale was conducted under a Rule 10b5-1 trading plan. This transaction follows a significant 216% surge in Septerna's share price over

Tone
Positive 63/100
Event
Market update
Published
01 Jul 2026 05:39
Source
Investing.com
Stock Titan Direct company coverage

Septerna (SEPN) director Jeffrey Tong granted options on 15,000 shares

Septerna, Inc. director Jeffrey K. Tong was granted stock options for 15,000 shares of common stock. The options have an exercise price of $37.34 per share and expire on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the date of Septerna’s next

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 05:39
Source
Stock Titan
Stock Titan Direct company coverage

Septerna (SEPN) director Bernard Coulie receives 15,000 stock options

Septerna, Inc. (SEPN) director Bernard Coulie was granted 15,000 stock options with an exercise price of $37.34 per share, expiring on June 25, 2036. The options will vest in full by the earlier of June 26, 2027, or the company's next annual stockholders' meeting, provided he con

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 00:42
Source
Stock Titan
Stock Titan Direct company coverage

Septerna (NASDAQ: SEPN) director-linked funds get 15,000-share option

Septerna, Inc. (NASDAQ: SEPN) has granted a stock option for 15,000 shares of common stock at an exercise price of $37.34, expiring on June 25, 2036. This option, which vests upon the earlier of June 26, 2027, or the next annual stockholder meeting, is held by Dr. Simson for the

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 00:39
Source
Stock Titan
Stock Titan Direct company coverage

Septerna (SEPN) director Shalini Sharp receives stock options on 15,000 shares

Septerna, Inc. director Shalini Sharp was granted stock options for 15,000 shares of common stock. The options have an exercise price of $37.34 per share and will expire on June 25, 2036. These options will vest in full on the earlier of June 26, 2027, or the company's next annua

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 22:42
Source
Stock Titan
Market source Direct company coverage

Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?

An insider at Septerna, Daniel D. Long, SVP of Drug Discovery, sold 15,000 shares of common stock after exercising options, reducing his direct holdings by 13.46%. Despite this sale, the article suggests it's likely a form of income supplementation rather than a lack of confidenc

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 03:10
Source
Market source
TradingView Direct company coverage

ETFs Investing in Septerna, Inc. Stocks

This article lists various ETFs that hold Septerna, Inc. (SEPN) stocks, providing detailed information such as market value, weight, issuer, management style, focus, and expense ratio for each fund. The data highlights ETFs from major issuers like BlackRock, State Street, and Inv

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 16:10
Source
TradingView